Your Article Summary
See Latest ArticlesReliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen
Bone Marrow Transplantation, 06/23/09
Beri R et al. - In patients who had a test dose, a significant correlation between the first and subsequent doses of BU during the conditioning regimen was observed. The findings may allow more centers to pursue transplant strategies with targeted BU by overcoming the time limitation for PK studies during the conditioning regimen.
D Rondelli, 06/23/09
| The use of targeted doses of busulfan allows us to give to every patient the right dose of chemotherapy prior to a stem cell transplant. Because busulfan pharmacokinetics studies are not performed in the majority of the hospitals, it may be difficult for many centers to arrange for these tests to be obtained within 24-48 hours. By showing that a test dose 2 weeks before transplant is reliable and does not require the doctors to receive the results within 24-48 hours we hope to facilitate the use of targeted busulfan in many transplant centers. |
Related Articles
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing program
Pediatric Blood & Cancer, 11/12/09
Relevance Score: 67%
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non Hodgkin's lymphoma and chronic lymphocytic leukemia
Blood, 12/02/09
Relevance Score: 66%
Adolor Corporation Initiates Clinical Testing in Opioid Bowel Dysfunction Program
Adolor Corporation, 11/13/09
Relevance Score: 66%
Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing
Translational Research, The Journal of Laboratory and Clinical Medicine, 11/20/09
Relevance Score: 65%
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
Cancer Chemotherapy and Pharmacology, 11/18/09
Relevance Score: 65%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Factors Predicting Long Term Survival After T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
Haematologica, 12/08/09
Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation: A Clinical Review
American Journal of Clinical Oncology, 12/08/09
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Bone Marrow Transplantation, 12/03/09